Biosimilar sales to reach $6.5B by 2024, study says

Biosimilar sales to reach $6.5B by 2024, study says

Source: 
Beckers Hospital Review
News Tags: 
snippet: 

Biosimilar sales are expected to nearly triple in the coming years, from about $2.5 billion last year to more than $6.5 billion in 2024, according to an S&P Global Ratings analysis cited by STAT.